Literature DB >> 7979067

Cell biology of human vascular smooth muscle.

P Chan1.   

Abstract

Vascular smooth muscle is the cellular substrate of most significant arterial diseases. Restenosis after angioplasty and surgery mainly represents vascular smooth muscle reaction to trauma, a process which is also significant in the early stages of atherogenesis. Empirical approaches, based on findings in animal models of vascular injury, have notably failed to make any impact on human restenosis. We have developed and validated growth of the human VSMC in culture as a model of restenosis. Intimal hyperplastic lesions producing vascular restenosis contain cells that have reduced sensitivity to physiological growth inhibition by heparin in cell culture conditions, compared with cells from normal vascular tissue. Undiseased saphenous vein obtained from patients with intimal hyperplastic restenoses also contain cells that are relatively resistant to heparin inhibition. Arterial healing that progresses to restenosis may have distinct and fundamental differences at the cellular level from the normal process of arterial healing after injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979067      PMCID: PMC2502406     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  31 in total

1.  Effect of restenosis after an earlier angioplasty at another coronary site on the frequency of restenosis after a subsequent coronary angioplasty.

Authors:  P B Berger; M R Bell; D R Holmes; L Hammes; J L Kosanke; S J Bresee
Journal:  Am J Cardiol       Date:  1992-04-15       Impact factor: 2.778

2.  Quantitative analysis of coronary artery restenosis after coronary angioplasty--has the rose lost its bloom?

Authors:  K L Gould
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

3.  Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis.

Authors:  P Chan; M Patel; L Betteridge; E Munro; M Schachter; J Wolfe; P Sever
Journal:  Lancet       Date:  1993-02-06       Impact factor: 79.321

4.  Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro.

Authors:  S Björkerud
Journal:  Arterioscler Thromb       Date:  1991 Jul-Aug

5.  Heparin inhibition of human vascular smooth muscle cell hyperplasia.

Authors:  P Chan; S Mill; B Mulloy; V Kakkar; C Demoliou-Mason
Journal:  Int Angiol       Date:  1992 Oct-Dec       Impact factor: 2.789

6.  Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing.

Authors:  S J Bresee; A K Jacobs; G R Garber; N A Ruocco; R M Mills; B A Bergelson; T J Ryan; D P Faxon
Journal:  Am J Cardiol       Date:  1991-11-01       Impact factor: 2.778

7.  Cellular biology of human intimal hyperplastic stenosis.

Authors:  P Chan; E Munro; M Patel; L Betteridge; M Schachter; P Sever; J Wolfe
Journal:  Eur J Vasc Surg       Date:  1993-03

Review 8.  Experimental models of coronary artery restenosis.

Authors:  D W Muller; S G Ellis; E J Topol
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

9.  Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology.

Authors:  J G Pickering; L Weir; K Rosenfield; J Stetz; J Jekanowski; J M Isner
Journal:  J Am Coll Cardiol       Date:  1992-11-15       Impact factor: 24.094

10.  Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury.

Authors:  M W Majesky; C M Giachelli; M A Reidy; S M Schwartz
Journal:  Circ Res       Date:  1992-10       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.